M&A Deal Summary

Seven2 Acquires AEB

On September 20, 2018, private equity firm Seven2 acquired life science company AEB from Investindustrial and SK Capital Partners

Acquisition Highlights
  • This is Seven2’s 1st transaction in the Life Science sector.
  • This is Seven2’s 1st transaction in Italy.

M&A Deal Summary

Date 2018-09-20
Target AEB
Sector Life Science
Buyer(s) Seven2
Sellers(s) Investindustrial
SK Capital Partners
Deal Type Secondary Buyout

Target

AEB

Brescia, Italy
AEB is a provider of biotechnology solutions and process enablers for the food and beverage sector, particularly for the oenology market. AEB offers a wide range of products, allowing users to take advantage of the most innovative wine processing and treatment techniques. AEB was founded in 1963 and is based in Brescia, Italy.

Search 214,981 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Seven2

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1972
PE ASSETS 5.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Seven2 is a private equity firm focused on investments in listed and unlisted small and midcap companies located in Continental Europe. The Firm targets growing businesses in the tech and telecom, consumer, and healthcare services sectors valued between €10 million and €1 billion. Seven2 generally has a five year investment horizon and considers minority and majority positions. Seven2 was established in 1972 and is headquartered in Paris, France.


DEAL STATS #
Overall 12 of 37
Sector: Life Science M&A 1 of 2
Type: Secondary Buyout M&A Deals 6 of 17
Country: Italy M&A 1 of 2
Year: 2018 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-05-25 Expereo International

Amsterdam, Netherlands

Expereo International is a provider of managed Internet network services, SD-WAN, Security and Cloud Connectivity optimisation solutions for global enterprises. Expereo International was founded in 2004 and is based in Amsterdam, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-23 Efficy

Brussels, Belgium

Efficy is a software provider offering medium & large businesses a complete, flexible and extended CRM (Customer Relationship Management) solution that helps companies manage their Customer Relationship. Efficy offers an all-in-one CRM (Customer Relationship Management) solution, developed specifically to meet the needs of medium and large enterprises. Efficy was founded in 2005 and is based in Brussels, Belgium.

Buy -

Seller(S) 2

SELLER

Investindustrial

London, United Kingdom

Investor


Category Private Equity Firm
Founded 1990
PE ASSETS 11.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Investindustrial is an investment firm focused on creating global leaders through organic growth and acquisitions. The Firm is operationally driven and seeks opportunities in Southern Europe. Areas of interest include services, consumer, retail, leisure, and industrial manufacturing. Investindustrial has offices in London, Luxembourg, Milan, Lugano, Barcelona, Shanghai, and New York.


DEAL STATS #
Overall 26 of 35
Sector: Life Science M&A 1 of 1
Type: Secondary Buyout M&A Deals 4 of 6
Country: Italy M&A 13 of 15
Year: 2018 M&A 5 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-09-12 Louis Poulsen Lighting

Copenhagen, Denmark

Louis Poulsen Lighting is a manufacturer and distributor of lighting fixtures. Louis Poulsen Lighting was founded in 1874 and is based in Copenhagen, Denmark.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-08 Aston Martin

Gaydon, United Kingdom

Aston Martin is a luxury car manufacturer and one of the most exclusive sports car brands in the world. Aston Martin was founded in 2018 and is based in Gaydon, United Kingdom.

Sell -
SELLER

SK Capital Partners

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2007
PE ASSETS 4.9B USD
Size Large
Type Sector Agnostic
DESCRIPTION

SK Capital Partners is a private investor in mature and middle-market companies located throughout North America. SK Capital focuses on companies with opportunities for substantial business improvement and strong growth prospects. The Firm looks to invest $100 to $200 million of equity in transactions valued up to $500 million. Prospective businesses typically generate $50 to $500 million in revenues and at least $100 million in EBITDA. Areas of interest include specialty materials, chemicals and healthcare. The Firm will consider a variety of transaction situations, including buyouts, recapitalizations, growth equity financings, and corporate carve-outs. SK Capital Partners was spun out of Arsenal Capital Partners and became independent in 2007. SK Capital Partners is based in New York City.


DEAL STATS #
Overall 5 of 16
Sector: Life Science M&A 1 of 2
Type: Secondary Buyout M&A Deals 2 of 2
Country: Italy M&A 1 of 1
Year: 2018 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-07-23 Cambrex Drug Product- Business Unit

Whippany, New Jersey, United States

Cambrex Drug Product's Business Unit is a technology-focused contract manufacturing business with differentiated applications and capabilities in solid, semi-solid and liquid dosage forms, with a particular focus on controlled substances. Cambrex Drug Product's Business Unit was established in 2006 and is based in Whippany, New Jersey.

Sell $425M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-23 VanDeMark

Lockport, New York, United States

VanDeMark is a provider of specialty and custom chemicals focusing on phosgene production and phosgene-related chemistry. These products are used in pharmaceuticals, agricultural chemicals, polymers, sealants, coatings, and biocides. VanDeMark was founded in 1951 and is based in Lockport, New York.

Buy -